Overexpression of serine-threonine receptor kinase-associated protein in colorectal cancers

Pathology International

Volumn 57, Issue 4, 2007, Pages 178-182

  Kim, Chang Jae ^a   Choi, Byung Jun ^a   Song, Jae Hwi ^a   Park, Yong Kyu ^a   Cho, Yong Gu ^a   Nam, Suk Woo ^a   Yoo, Nam Jin ^a   Lee, Jung Young ^a   Park, Won Sang ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Colon cancer; Expression; Immunohistochemistry; Serine threonine receptor kinase; Tissue microarray

Indexed keywords

KI 67 ANTIGEN; PROTEIN SERINE THREONINE KINASE; SERINE THREONINE RECEPTOR KINASE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; COLON ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL ANALYSIS; TISSUE MICROARRAY; TUMOR CELL; UPREGULATION;

ADENOMA; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; NEOPLASM PROTEINS; UP-REGULATION;

EID: 33847142379     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02078.x     Document Type: Article

References (17)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005; 365: 153-65.
2. Shin HR, Jung KW, Won YJ, Park JG. 139 KCCR-affiliated hospitals 2002 Annual report of the Korea central cancer registry: Based on registered data from 139 hospitals. J Korean Cancer Assoc 2004; 36: 103-14.
3. Bissell DM. Chronic liver injury, TGF-β and cancer. Exp Mol Med 2001; 33: 179-90.
4. Kloos DU, Choi C, Wingender E. The TGF-beta-Smad network: Introducing bioinformatic tools. Trends Genet 2002; 18: 96-103.
5. Moustakas A, Pardali K, Gaal A, Heldin C. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett 2002; 82: 85-91.
6. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-30.
7. Alexandrow MG, Moses HL. Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription. Cancer Res 1995; 55: 1452-7.
8. Cohen MM Jr. TGF beta/Smad signaling system and its pathologic correlates. Am J Med Genet 2003; 116A: 1-10.
9. Datta PK, Chytil A, Gorska AE, Moses HL. Identification of STRAP, a novel WD domain protein in transforming growth factor-β signaling. J Biol Chem 1998; 273: 34 671-4.
10. Halder SK, Anumanthan G, Maddula R et al. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Cancer Res 2006; 66: 6156-66.
11. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139: 846-51.
12. Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-7.
13. Weiser R. The transforming growth factor-beta signaling pathway in tumorigenesis. Curr Opin Oncol 2001; 13: 70-77.
14. Engle SJ, Ormsby I, Pawlowski S et al. Elimination of colon cancer in germ-free transforming growth factor β1-deficient mice. Cancer Res 2002; 62: 6362-6.
15. Waite KA, Eng C. From developmental disorder to heritable cancer: It's all in the BMP/TGF-β family. Nat Rev Genet 2003; 4: 763-73.
16. Grady WM, Myeroff LL, Winler SE et al. Mutational inactivation of transforming growth factor β-receptor type II in microsatellite stable colon cancers. Cancer Res 1999; 59: 320-24.
17. Buess M, Terracciano L, Reuter J et al. STRAP is a strong predictive marker of adjuvant chemotherapy benefit in colorectal cancer. Neoplasia 2004; 6: 813-20.